|
|
STRONTIUM
Bone loss accelerates suddenly in menopausal women because the drop in estrogen levels causes an increase in the resorption (teardown) of existing bone. But resorption is only half of the story. Age-related bone loss is also caused by a decrease in the formation of new bone tissue.
Existing drugs for treating osteoporosis, as well as calcium and vitamin D supplements, work by reducing bone resorption. But they do not support the formation of new bone. These drugs and nutrients increase the mineralization of bone, but they do not help the body to build new bone tissue. The resulting bone is less prone to fracture, but is not the same as youthful, healthy bone.
Strontium is a mineral found along with calcium in most foods. Research has long suggested that it may be an essential nutrient required for the normal development, structure, function, and health of the skeletal system. Clinical trials going back into the 1940s have supported this conclusion, but recent studies have provided evidence that it can offer unique nutritional support against loss of bone structure and function.
Animal studies have shown that Strontium supplements both decrease bone resorption, and increase the formation of new bone tissue.
•In animal models, Strontium causes “baby” osteoblasts (bone-building cells) to multiply more quickly.
•Bone tissue cultures which are exposed to Strontium synthesize more bone matrix and new bone collagen. The same amount of calcium has no effect on these parameters.
•In bone tissue culture, Strontium reduces bone resorption at concentrations at which calcium has no effect, prevents the resorption caused by excessive parathyroid hormone, and slows the rate at which immature osteoclasts develop.
•Strontium-supplemented diets boost bone strength in experimental animals without a negative impact on bone quality, even at extremely high doses.
Human clinical trials also support Strontium’s ability to both support new bone formation and prevent excessive resorption.
•Early clinical trials’ results led researchers to speculate that Strontium increased osteoblast activity.
•Bone biopsies from a small pilot trial revealed an astounding 172.4% increase in new bone formation after six months of Strontium supplementation.
•The bone-building activity of osteoblasts can be measured using bone-specific alkaline phosphatase, while crosslinked N-telopeptide (NTx) and C-telopeptide (CTx) mark the degradation of bone collagen by ravaging osteoclasts. The use of these tests in large clinical trials has confirmed that Strontium supplements decrease bone resorption and also stimulate bone-building osteoblast activity and new bone formation in women with osteoporosis.
Unlike the range of side-effects that accompany bisphosphonates and other antiresorptive drugs, no side-effects have ever been reported that could be attributed to Strontium. People experienced no symptomatic or chemical or physiological signs of toxicity after taking Strontium supplements for as long as four years, at two and a half times the dose of elemental Strontium that’s used in today’s clinical trials.
STRONTIUM SUPPORT |
| Quantity in Basket:none
Code: 4015
Price:$44.00
Shipping Weight: 0.00 pounds
|
|
| | 90 Vegi-Caps |
Related Item(s) |
| Code
|
Name
|
Price
|
Description
|
|
|
4013
|
Goat Mineral Matrix
|
$0.00
|
400 gm. and 1000 gm.
|
|
4014
|
PEAK K2 - MENATETRENONE
|
$0.00
|
90 Vegetarian Capsules - 15 mg.
|
|
4019
|
ORTHO-BONE
|
$65.00
|
300 Capsules
|
|
4018
|
VITAMIN D3 - 1000
|
$24.00
|
120 Capsules
|
|
90 VEGI-CAPS
720 mg
SUPPLEMENT FACTS:
Serving Size: 1 Capsule
%DRI
Strontium (citrate) ............................. 227 mg
*
* Dietary Reference Intake not established.
Other ingredients: microcrystalline cellulose. Capsule: Vegetarian
100% VEGETARIAN
|
|
|
